NCT06698939View on ClinicalTrials.gov

ORKA-001 in Healthy Volunteers

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 19, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Healthy Volunteers
Interventions
DRUG

ORKA-001

ORKA-001 is supplied as sterile solution to be administered by SC injection

OTHER

Placebo

Placebo solution to be administered at a matching volume by SC injection

Trial Locations (1)

Unknown

Oruka Therapeutics Investigative Site, Christchurch

Sponsors
All Listed Sponsors
lead

Oruka Therapeutics, Inc.

INDUSTRY

NCT06698939 - ORKA-001 in Healthy Volunteers | Biotech Hunter | Biotech Hunter